3D CELL CULTURE - SMi conference
20. Februar 2019
TEDD is sponsoring the symposium in London, where we look at the latest developments in the 3D Cell Culture field. You can visit us at our exhibition booth and listen to the talk of Michael Raghunath, our TEDD Director.
February 20-21, 2019 | London, United Kingdom
Cell Culture in an important tool for research and development within the life science industry. Over the past few years, 3D Cell Culture has gained momentum within the pharmaceutical industry due to the benefits that this model offers over conventional cell culture methods. 3D cell culture enables cells to grow and interact with their surroundings in all three dimensions, better mimicking the in-vivo conditions in which the cells are naturally present. This enhances the ability for scientists to study basic biological mechanisms such as cell number monitoring, cell viability, proliferation and morphology. 3D cell cultures also have greater stability and longer life spans.
Researchers globally are realizing the potential of 3D cell culture for various applications, including testing and discovering new drugs to treat cancer, organ-on-chip models to study the human physiology in an organ specific context, and 3D cell printing to produce organ models. Therefore, this market is likely to grow over the next few years and is in fact projected to reach USD 1.7 Million by 2022, growing at a CAGR of 20.3% between 2017-2022. Growth in this market is also driven by global factors such as a need for alternative methods to animal resting, funding from governments and private entities and technological advancements in the field.
Join us in February 2019, as we look at the latest developments in the 3D Cell Culture field. Network with industry experts, gain insight into how the pharmaceutical industry is utilizing 3D Cell Culture technologies to enhance research and development, discuss the potential for novel in-vitro cell culture models to replace animal models, and discover novel 3D cell culture systems, organ-on-chip, 3D imaging of organoids and other technologies in development.
At day 1 Michael Raghunath, Head Center for Cell Biology & Tissue Engineering Director Competence Center TEDD will give talk
AMPLIFICATION OF EXTRACELLULAR MATRIX VIA MACROMOLECULAR CROWDING IN 2D, 3D, CELL CULTURE AND IN BIOPRINTING
- The importance of the cellular microenvironment in controlling cell behavior and fate.
- Current highly aqueous culture conditions impair efficient ECM deposition
- Overcoming this issue by introducing macromolecular crowding (MMC) into the culture medium of monolayer cultures or hydrogels
- MMC adopted by the pharma industry for antifibrotic screening: production of stem cell matrix, and tuning the microarchitecture of bioprinted collagen hydrogels
Von: 20. Februar 2019
Bis: 21. Februar 2019